Previous
Previous

VentureMed Group Closes $28M Series C Funding to Accelerate CommercialAdoption and Expand Indications for the FLEX VPTM System.

Next
Next

SpectraWAVE Receives 510(k) Clearance for X1™-FFR, an AI-enabled, Wire-Free, Drug-Free, Single Angiogram Physiology Solution